0 Σχόλια
0 Μοιράστηκε
95 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
mTOR Inhibitor Oncology Drug Market Strengthens with Rising Cancer Research Investments"Detailed Analysis of Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period With this mTOR Inhibitor Oncology Drug Market report,...0 Σχόλια 0 Μοιράστηκε 60 Views 0 Προεπισκόπηση
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Σχόλια 0 Μοιράστηκε 10 Views 0 Προεπισκόπηση
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Σχόλια 0 Μοιράστηκε 649 Views 0 Προεπισκόπηση
-
Global Oncology Information System Market to Reach $4.65 Billion by 2033Market Overview The global oncology information system market size was valued at USD 2.43 billion in 2024 and it is projected to reach from USD 2.61 billion in 2025 to USD 4.65 billion by 2033, growing at a CAGR of 7.5% during the forecast period (2025-2033). The global Oncology Information System market continues to evolve rapidly, driven by...0 Σχόλια 0 Μοιράστηκε 584 Views 0 Προεπισκόπηση
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Spatial Genomics and Transcriptomics Market Future Scope: Growth, Share, Value, Size, and Analysis"Executive Summary Spatial Genomics and Transcriptomics Market Size and Share: Global Industry Snapshot The global spatial genomics and transcriptomics market size was valued at USD 1.22 billion in 2024 and is projected to reach USD 11.36 billion by 2032, with a CAGR of 21.30% during the forecast period of 2025 to 2032. Spatial Genomics and Transcriptomics Market report offers...0 Σχόλια 0 Μοιράστηκε 6χλμ. Views 0 Προεπισκόπηση
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Σχόλια 0 Μοιράστηκε 9 Views 0 Προεπισκόπηση
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Σχόλια 0 Μοιράστηκε 10 Views 0 Προεπισκόπηση
English
Kiswahili
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
